Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
The observations are procedural in nature and will be responded to within the stipulated time
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
During the quarter, Zydus Wellness completed the acquisition of Comfort Click Limited and its subsidiaries
Results demonstrate favorable safety profile and clinically meaningful improvements in patients with non-ischemic heart failure
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
The U.S. FDA issued a Form 483 with five observations
At the end of the current inspection, a 'Form 483' was issued with 5 observations which are procedural in nature and no data integrity issues were reported
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
Subscribe To Our Newsletter & Stay Updated
